The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 23, 2018
Filed:
Sep. 03, 2015
Applicant:
The Curators of the University of Missouri, Columbia, MO (US);
Inventor:
Peter Koulen, Kansas City, MO (US);
Assignee:
The Curators of the University of Missouri, Columbia, MO (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 3/024 (2006.01); A61B 3/113 (2006.01); A61B 5/00 (2006.01); A61B 3/00 (2006.01); A61B 3/10 (2006.01); A61B 3/12 (2006.01); A61B 5/107 (2006.01);
U.S. Cl.
CPC ...
A61B 5/4088 (2013.01); A61B 3/0025 (2013.01); A61B 3/0091 (2013.01); A61B 3/024 (2013.01); A61B 3/102 (2013.01); A61B 3/1005 (2013.01); A61B 3/113 (2013.01); A61B 3/1225 (2013.01); A61B 5/1075 (2013.01); A61B 5/7282 (2013.01); A61B 5/6821 (2013.01);
Abstract
Systems and methods are described herein for determining that a patient has indications mild cognitive impairment (MCI) or early stage Alzheimer's disease (AD). Microperimetry is used to assess the functional integrity of the patient's retina. Optical Coherence Tomography is used to assess the structural integrity of the patient's retina. Reductions in the size and function of the patient's retina indicate that the patient may have MCI or early stage AD.